| Primary |
| Psoriasis |
86.5% |
| Hepatitis |
3.8% |
| Hyperkeratosis |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Rash |
1.9% |
| Vitamin Supplementation |
1.9% |
| Eczema |
1.0% |
| Pruritus |
1.0% |
|
| Off Label Use |
16.4% |
| Pustular Psoriasis |
11.5% |
| Psoriasis |
8.2% |
| Cataract |
4.9% |
| Dermatitis Exfoliative |
4.9% |
| Vomiting |
4.9% |
| Weight Decreased |
4.9% |
| Weight Increased |
4.9% |
| Acute Generalised Exanthematous Pustulosis |
3.3% |
| Adrenocortical Insufficiency Acute |
3.3% |
| Anaphylactic Reaction |
3.3% |
| Cardiac Failure Congestive |
3.3% |
| Chorioretinopathy |
3.3% |
| Dermatitis Herpetiformis |
3.3% |
| Drug Exposure During Pregnancy |
3.3% |
| Dyspnoea |
3.3% |
| Erysipelas |
3.3% |
| Erythrodermic Psoriasis |
3.3% |
| Generalised Oedema |
3.3% |
| Guttate Psoriasis |
3.3% |
|
| Secondary |
| Psoriasis |
42.1% |
| Product Used For Unknown Indication |
21.1% |
| Hormone Replacement Therapy |
10.5% |
| Diabetes Mellitus |
5.3% |
| Drug Use For Unknown Indication |
3.5% |
| Pain |
3.5% |
| Bipolar Disorder |
1.8% |
| Foetal Exposure During Pregnancy |
1.8% |
| Gastric Disorder |
1.8% |
| Hepatitis |
1.8% |
| Hypothyroidism |
1.8% |
| Parathyroid Gland Operation |
1.8% |
| Pruritus |
1.8% |
| Scab |
1.8% |
|
| Weight Decreased |
21.1% |
| Acute Myocardial Infarction |
5.3% |
| Chorioretinopathy |
5.3% |
| Eczema |
5.3% |
| Neonatal Aspiration |
5.3% |
| Nephrolithiasis |
5.3% |
| Pneumonia Primary Atypical |
5.3% |
| Postoperative Wound Infection |
5.3% |
| Prostate Cancer |
5.3% |
| Red Blood Cell Sedimentation Rate Increased |
5.3% |
| Renal Failure |
5.3% |
| Scab |
5.3% |
| Skin Reaction |
5.3% |
| Sleep Apnoea Syndrome |
5.3% |
| Suicide Attempt |
5.3% |
| Thermal Burn |
5.3% |
|
| Concomitant |
| Psoriasis |
39.3% |
| Product Used For Unknown Indication |
26.1% |
| Psoriatic Arthropathy |
5.9% |
| Hypertension |
4.9% |
| Drug Use For Unknown Indication |
3.4% |
| Pain |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Diabetes Mellitus |
2.5% |
| Anxiety |
1.9% |
| Depression |
1.7% |
| Hypersensitivity |
1.7% |
| Vitamin Supplementation |
1.3% |
| Hypothyroidism |
1.2% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Blood Pressure |
0.7% |
| Insomnia |
0.7% |
| Crohn's Disease |
0.7% |
| Supplementation Therapy |
0.7% |
| Asthma |
0.6% |
|
| Psoriasis |
19.4% |
| Drug Ineffective |
7.3% |
| Injection Site Pain |
7.3% |
| Therapeutic Response Decreased |
6.5% |
| Urinary Tract Infection |
5.6% |
| Nasopharyngitis |
4.8% |
| Sinusitis |
4.8% |
| Swelling |
4.8% |
| Injection Site Pruritus |
4.0% |
| Abdominal Pain |
3.2% |
| Complication Of Pregnancy |
3.2% |
| Guillain-barre Syndrome |
3.2% |
| Injection Site Erythema |
3.2% |
| Injection Site Swelling |
3.2% |
| Latent Tuberculosis |
3.2% |
| Pain |
3.2% |
| Pruritus |
3.2% |
| Upper Respiratory Tract Infection |
3.2% |
| Visual Impairment |
3.2% |
| Weight Decreased |
3.2% |
|
